Krogerus advises MB Funds on its investment in Pharmatory

Krogerus advised MB Funds on its investment in Pharmatory, a Finnish contract development and manufacturing company (“CDMO”) specializing in small molecule active pharmaceutical ingredients (“APIs”). The management of Pharmatory continues to develop the company in their current roles and as significant owners together with MB Funds.

Pharmatory, founded in 2001, provides services for global pharma and biotech companies in medicine development with CDMO offering for human and veterinary pharmaceuticals. The company’s service offering includes analytical, process R&D and contract manufacturing services according to Good Manufacturing Practice (GMP). The company’s operations are based on long-term partnerships with its clients. Pharmatory has facility in Oulu, Finland, with a team of highly skilled and experienced professionals in the field of chemistry.

The Krogerus team was led by Partner Sami Martola and he was primarily assisted by Senior Associates Nicklas Svento and Julius Viherkenttä and Associates Oona-Maria Kultti and Marko Katainen.